US FDA Approves New Opioid Prodrug, Apadaz, For The Treatment Of Pain

 

Company: KemPharm, Inc.

Generic Name: acetaminophen and benzhydrocodone hydrochloride 

Dosage: Tablets

Previous Name: KP201

Treatment For: Pain

General information about Apadaz

The FDA has approved Apadaz (benzhydrocodone and acetaminophen) oral tablets for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Apadaz (acetaminophen and benzhydrocodone hydrochloride) is a narcotic analgesic combination for the short-term management of acute pain.

The ingredient benzhydrocodone is a prodrug of the opioid agonist hydrocodone, meaning that while the ingredient is initially inactive, is it converted to active hydrocodone by enzymes in the intestinal tract.